ArticleMycopathologia2017
Large-Scale Land Development, Fugitive Dust, and Increased Coccidioidomycosis Incidence in the Antelope Valley of California, 1999-2014.
Article in Mycopathologia, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 43 citations in OpenAlex.
- Impacts of land use and fallowing on coccidioidomycosis incidence in California: A population-based longitudinal study.Science advances · 2026Article
- Hypothesis on the dust-borne atmospheric transport of Coccidioides, causative fungal pathogen for coccidioidomycosis (Valley fever).Medical mycology · 2026Article
- Detection of AirborneEnvironmental science & technology letters · 2025Article
- Detection of airbornebioRxiv : the preprint server for biology · 2025Article
- Estimating the Exposure-Response Relationship between Fine Mineral Dust Concentration and Coccidioidomycosis Incidence Using Speciated Particulate Matter Data: A Longitudinal Surveillance Study.Environmental health perspectives · 2025Article
- Valley Fever: Fine Mineral Dust Modeling Points to High-Risk Regions and Seasons in California.Environmental health perspectives · 2025Article
- Climate change and public health in California: A structured review of exposures, vulnerable populations, and adaptation measures.Proceedings of the National Academy of Sciences of the United States of America · 2024Review
- A microbial risk assessor's guide to Valley Fever (Coccidioides spp.): Case study and review of risk factors.The Science of the total environment · 2024Review
- Update on the Epidemiology, Diagnosis, and Treatment of Coccidioidomycosis.Journal of fungi (Basel, Switzerland) · 2022Review
- PM10 and Other Climatic Variables Are Important Predictors of Seasonal Variability of Coccidioidomycosis in Arizona.Microbiology spectrum · 2022Article
- Article
- Endemic and Other Dimorphic Mycoses in The Americas.Journal of fungi (Basel, Switzerland) · 2021Review
- Economic Valuation of Coccidioidomycosis (Valley Fever) Projections in the United States in Response to Climate Change.Weather, climate, and society (Print) · 2021Article
- Using soil survey data to model potential Coccidioides soil habitat and inform Valley fever epidemiology.PloS one · 2021Article
- Valley Fever: Environmental Risk Factors and Exposure Pathways Deduced from Field Measurements in California.International journal of environmental research and public health · 2020Article
- Suspected Locally Acquired Coccidioidomycosis in Human, Spokane, Washington, USA.Emerging infectious diseases · 2020Article
- Investigating the Role of Animal Burrows on the Ecology and Distribution of Coccidioides spp. in Arizona Soils.Mycopathologia · 2020Article
- The mysterious desert dwellers: Coccidioides immitis and Coccidioides posadasii, causative fungal agents of coccidioidomycosis.Virulence · 2019Review
- Expansion of Coccidioidomycosis Endemic Regions in the United States in Response to Climate Change.GeoHealth · 2019Article
- Utility of Whole-Genome Sequencing to Ascertain Locally Acquired Cases of Coccidioidomycosis, Washington, USA.Emerging infectious diseases · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ongoing large-scale land development for renewable energy projects in the Antelope Valley, located in the Western Mojave Desert, has been blamed for increased fugitive dust emissions and coccidioidomycosis incidence among the general public in recent years. Soil samples were collected at six sites that were destined for solar farm construction and were analyzed for the presence of the soil-borne fungal pathogen Coccidioides immitis which is endemic to many areas of central and southern California. We used a modified culture-independent nested PCR approach to identify the pathogen in all soil samples and also compared the sampling sites in regard to soil physical and chemical parameters, degree of disturbance, and vegetation. Our results indicated the presence of C. immitis at four of the six sites, predominantly in non-disturbed soils of the Pond-Oban complex, which are characterized by an elevated pH and salt bush communities, but also in grassland characterized by different soil parameters and covered with native and non-native annuals. Overall, we were able to detect the pathogen in 40% of the soil samples (n = 42). Incidence of coccidioidomycosis in the Antelope Valley was positively correlated with land use and particulate matter in the air (PM10) (Pearson correlation coefficient >0.5). With the predicted population growth and ongoing large-scale disturbance of soil in the Antelope Valley in coming years, incidence of coccidioidomycosis will likely further increase if policy makers and land developers continue to ignore the risk of grading land without implementing long-term dust mitigation plans in Environmental Impact Reports.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.